|
PL366639A1
(en)
|
2001-04-20 |
2005-02-07 |
Wyeth |
Heterocyclylalkoxy-, -alkylthio- and -alkylaminobenzazole derivatives as 5-hydroxytryptamine-6 ligands
|
|
FR2836915B1
(fr)
|
2002-03-11 |
2008-01-11 |
Aventis Pharma Sa |
Derives d'aminoindazoles, procede de preparation et intermediaires de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
|
|
US20030139427A1
(en)
|
2002-08-23 |
2003-07-24 |
Osi Pharmaceuticals Inc. |
Bicyclic pyrimidinyl derivatives and methods of use thereof
|
|
KR100976076B1
(ko)
|
2003-05-22 |
2010-08-17 |
아보트 러보러터리즈 |
인다졸, 벤즈이속사졸 및 벤즈이소티아졸 키나제 억제제
|
|
EP1647549A1
(en)
|
2004-10-14 |
2006-04-19 |
Laboratoire Theramex |
Indazoles, benzisoxazoles and benzisothiazoles as estrogenic agents
|
|
CA2626579A1
(en)
|
2005-10-25 |
2007-05-03 |
Abbott Laboratories |
Formulation comprising a drug of low water solubility and method of use thereof
|
|
JP2009532375A
(ja)
|
2006-03-30 |
2009-09-10 |
タケダ サン ディエゴ インコーポレイテッド |
キナーゼ阻害剤
|
|
CN101553224A
(zh)
*
|
2006-10-06 |
2009-10-07 |
艾博特公司 |
新型咪唑并噻唑和咪唑并唑
|
|
JP2009007342A
(ja)
|
2007-06-01 |
2009-01-15 |
Mitsubishi Tanabe Pharma Corp |
医薬組成物
|
|
US8648069B2
(en)
|
2007-06-08 |
2014-02-11 |
Abbvie Inc. |
5-substituted indazoles as kinase inhibitors
|
|
WO2009147190A1
(en)
|
2008-06-05 |
2009-12-10 |
Glaxo Group Limited |
Novel compounds
|
|
JP5502076B2
(ja)
|
2008-06-05 |
2014-05-28 |
グラクソ グループ リミテッド |
新規化合物
|
|
WO2009147188A1
(en)
|
2008-06-05 |
2009-12-10 |
Glaxo Group Limited |
Benzpyrazol derivatives as inhibitors of pi3 kinases
|
|
JP2011529090A
(ja)
|
2008-07-28 |
2011-12-01 |
江蘇国華投資有限公司 |
アラルキルピペリジン(又はピペラジン)誘導体及びその統合失調症治療のための使用
|
|
JP2013501003A
(ja)
|
2009-07-31 |
2013-01-10 |
バイオクライスト ファーマシューティカルズ, インコーポレイテッド |
ヤヌスキナーゼ阻害剤としてのピロロ[1,2−b]ピリダジン誘導体
|
|
TW201111385A
(en)
|
2009-08-27 |
2011-04-01 |
Biocryst Pharm Inc |
Heterocyclic compounds as janus kinase inhibitors
|
|
FR2951172B1
(fr)
|
2009-10-13 |
2014-09-26 |
Pf Medicament |
Derives pyrazolopyridines en tant qu'agent anticancereux
|
|
WO2011067365A1
(en)
|
2009-12-03 |
2011-06-09 |
Glaxo Group Limited |
Benzpyrazole derivatives as inhibitors of p13 kinases
|
|
WO2011067364A1
(en)
|
2009-12-03 |
2011-06-09 |
Glaxo Group Limited |
Novel compounds
|
|
TW201200518A
(en)
|
2010-03-10 |
2012-01-01 |
Kalypsys Inc |
Heterocyclic inhibitors of histamine receptors for the treatment of disease
|
|
PT2635299T
(pt)
|
2010-11-02 |
2019-10-14 |
Univ Columbia |
Métodos de tratamento de distúrbios de perda de cabelo
|
|
US8846712B2
(en)
|
2011-09-12 |
2014-09-30 |
Sanofi |
6-(4-hydroxy-phenyl)-3-styryl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
|
|
WO2013037390A1
(en)
|
2011-09-12 |
2013-03-21 |
Sanofi |
6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
|
|
EP2567959B1
(en)
|
2011-09-12 |
2014-04-16 |
Sanofi |
6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
|
|
EP2760862B1
(en)
|
2011-09-27 |
2015-10-21 |
Sanofi |
6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
|
|
US20130102601A1
(en)
|
2011-10-21 |
2013-04-25 |
F. Hoffmann-La Roche Ltd |
Pyrimidin-4-one derivatives and their use in the treatment, amelioration or prevention of a viral disease
|
|
EP2771340B1
(en)
|
2011-10-25 |
2016-04-13 |
Sanofi |
6-(4-hydroxy-phenyl)-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
|
|
EP2788000B1
(en)
|
2011-12-06 |
2018-05-30 |
Merck Sharp & Dohme Corp. |
Pyrrolopyrimidines as janus kinase inhibitors
|
|
US8377946B1
(en)
|
2011-12-30 |
2013-02-19 |
Pharmacyclics, Inc. |
Pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitors
|
|
DK2830662T3
(da)
|
2012-03-29 |
2019-01-02 |
Univ Columbia |
Fremgangsmåder til behandlng af hårtabsforstyrrelser
|
|
EP2847191B1
(en)
|
2012-05-09 |
2016-06-15 |
Sanofi |
Substituted 6-(4-hydroxy-phenyl)-1h-pyrazolo[3,4-b]pyridine derivatives as kinase inhibitors
|
|
EP2892899B1
(en)
|
2012-09-06 |
2018-03-21 |
Bristol-Myers Squibb Company |
Imidazopyridazine jak3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases
|
|
TWI629275B
(zh)
|
2013-03-13 |
2018-07-11 |
賽諾菲公司 |
N-(4-(氮雜吲唑-6-基)-苯基)-磺醯胺及其作為醫藥之用途
|
|
LT3077395T
(lt)
|
2013-12-05 |
2018-02-12 |
Pfizer Inc. |
Pirolo[2,3-d]pirimidinilo, pirolo[2,3-b]pirazinilo ir pirolo[2,3-d]piridinilo akrilamidai
|
|
CA2937111A1
(en)
|
2014-01-24 |
2015-07-30 |
Abbvie Inc. |
6-phenyl- or 6-(pyridin-3-yl)indazole derivatives and methods of use
|
|
ES2774249T3
(es)
*
|
2014-02-14 |
2020-07-20 |
Respivert Ltd |
Compuestos heterocíclicos aromáticos como compuestos antiinflamatorios
|
|
PE20161475A1
(es)
|
2014-05-14 |
2017-01-08 |
Pfizer |
Pirazolopiridinas y pirazolopirimidinas
|
|
WO2016007731A1
(en)
|
2014-07-10 |
2016-01-14 |
Incyte Corporation |
Imidazopyridines and imidazopyrazines as lsd1 inhibitors
|
|
WO2016011394A1
(en)
|
2014-07-18 |
2016-01-21 |
The General Hospital Corporation |
Imaging agents for neural flux
|
|
CN107108556B
(zh)
|
2014-11-03 |
2020-09-29 |
艾欧米制药有限公司 |
药用化合物
|
|
CN105837574B
(zh)
|
2015-02-02 |
2018-03-02 |
四川大学 |
N‑(3‑哌啶基)‑芳香胺衍生物及其制备方法和用途
|
|
CA2984183C
(en)
*
|
2015-05-01 |
2021-11-09 |
Pfizer Inc. |
Pyrrolo[2,3-d]pyrimidinyl, pyrrolo[2,3-b]pyrazinyl, pyrrolo[2,3-b]pyridinyl acrylamides and epoxides thereof
|
|
AU2016259023A1
(en)
|
2015-05-07 |
2017-11-30 |
The Trustees Of Columbia University In The City Of New York |
Methods and compositions for promoting hair growth
|
|
EP3831830A1
(en)
|
2015-11-03 |
2021-06-09 |
Topivert Pharma Limited |
4,5,6,7-tetrahydro-1h-imidazo[4,5-c]pyridine and 1,4,5,6,7,8-hexahydroimidazo[4,5-d]azepine derivatives as janus kinase inhibitors
|
|
DK3712152T3
(da)
|
2015-11-03 |
2021-03-22 |
Topivert Pharma Ltd |
4,5,6,7-tetrahydro-1h-imidazo[4,5-c]pyridin og 1,4,5,6,7,8-hexahydroimidazo[4,5-d]azepinderivater som janus kinase-inhibitorer
|
|
US10973913B2
(en)
|
2016-02-16 |
2021-04-13 |
Washington University |
JAK inhibitors and uses thereof
|
|
RU2714206C1
(ru)
|
2016-06-30 |
2020-02-13 |
Даевунг Фармасьютикал Ко., Лтд. |
Пиразолопиримидиновые производные в качестве ингибитора киназы
|
|
WO2018036414A1
(zh)
|
2016-08-23 |
2018-03-01 |
北京诺诚健华医药科技有限公司 |
稠杂环类衍生物、其制备方法及其在医学上的应用
|
|
US9956158B2
(en)
|
2016-09-08 |
2018-05-01 |
Synergistic Therapeutics, Llc |
Topical hair growth formulation
|
|
CN110300590A
(zh)
|
2016-10-21 |
2019-10-01 |
林伯士拉克许米公司 |
Tyk2抑制剂及其用途
|
|
US20180117148A1
(en)
|
2016-10-28 |
2018-05-03 |
Andrew J. Holman |
Compounds, pharmaceutical compositions and methods of treatments of immune related diseases and disorders
|
|
WO2018098491A1
(en)
|
2016-11-28 |
2018-05-31 |
Praxis Precision Medicines, Inc. |
Compounds and their methods of use
|
|
KR102398659B1
(ko)
|
2017-03-17 |
2022-05-16 |
주식회사 대웅제약 |
카이네이즈 저해제로서의 피롤로트리아진 유도체
|
|
CN111032646B
(zh)
*
|
2017-08-01 |
2023-01-03 |
施万生物制药研发Ip有限责任公司 |
作为jak激酶抑制剂的吡唑并和三唑并双环化合物
|
|
BR112020008850A2
(pt)
|
2017-11-03 |
2020-10-20 |
Aclaris Therapeutics, Inc. |
composto, composição farmacêutica e método para tratar uma doença mediada por jak1 e jak3
|
|
KR102577242B1
(ko)
|
2017-12-28 |
2023-09-11 |
주식회사 대웅제약 |
카이네이즈 저해제로서의 아미노-메틸피페리딘 유도체
|
|
MA51431B1
(fr)
|
2017-12-28 |
2022-08-31 |
Daewoong Pharmaceutical Co Ltd |
Dérivés d'oxy-fluoropipéridine utilisés en tant qu'inhibiteur de kinase
|
|
KR102577241B1
(ko)
|
2017-12-28 |
2023-09-11 |
주식회사 대웅제약 |
카이네이즈 저해제로서의 아미노-플루오로피페리딘 유도체
|
|
WO2019182924A1
(en)
|
2018-03-21 |
2019-09-26 |
Xibin Liao |
Jak inhibitors
|
|
CN113498352A
(zh)
*
|
2019-01-23 |
2021-10-12 |
施万生物制药研发Ip有限责任公司 |
作为jak抑制剂的咪唑并[1,5-a]吡啶、1,2,4-三唑并[4,3-a]吡啶和咪唑并[1,5-a]吡嗪
|